We are the world's foremost drug discovery center focused solely on ALS (Amyotrophic Lateral Sclerosis).
Our innovative science and cutting edge approach have resulted in the identification of AT-1501, a promising treatment for ALS. We also pioneered the ALS Precision Medicine Program, the world's premier program and partnership with ALS patients to discover additional potential treatments.
As a nonprofit biotech we operate without regard to profit motive or politics. Led by people with ALS and drug development experts, we are funded by a global network of supporters unified to ending ALS in our lifetime.
ALS is not incurable, only underfunded. Support us in our race against time.
Register now for our upcoming webinar on May 10th at 6pm: FDA approves Radicava - What do we need to know?
#WHATWOULDYOUGIVE to #ENDALS?
For ALS Awareness Month, join our #InThreeWords campaign on social media.
You can be a hero and give to ALS TDI to help us get more promising treatments out of our lab and into people living with ALS.
DONATE
November 27 is
You've taken the challenge, now help move promising treatments out of our lab and into people living with ALS.
The 2018 Combined Federal Campaign has officially launched!
LEARN MORE
Yes, I have ALS. But I'm still Kate. I still consider myself a superhero, and with our powers combined, we can end ALS. -Kate